Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Storms

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|June 28, 2005
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitisJonathan Corren, William Storms, Jonathan Bernstein, et al.
Respiratory Medicine|November 6, 2004
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challengeWilliam Storms, Paul Chervinsky, Asma F Ghannam, et al.
Allergy & Rhinology (Providence, R.I.)|June 2, 2017
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitisCraig F LaForce, Warner Carr, Stephen A Tilles, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
Allergy and Asthma Proceedings|March 23, 2010
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitisCraig F LaForce, Warner Carr, Stephen A Tilles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 11, 2005
Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapyWilliam Berger, Mark B Abelson, Paulo J Gomes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2010
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by classMichael Benninger, Judith R Farrar, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2007
American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthmaJohn M Weiler, Sergio Bonini, Robert Coifman, et al.
The World Allergy Organization Journal|April 2, 2015
A World Allergy Organization international survey on physical activity as a treatment option for asthma and allergiesAndre Moreira, Matteo Bonini, Ruby Pawankar, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2011
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice ParametersBradley Chipps, Sheldon Spector, Judith Farrar, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|June 28, 2005
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitisJonathan Corren, William Storms, Jonathan Bernstein, et al.
Respiratory Medicine|November 6, 2004
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challengeWilliam Storms, Paul Chervinsky, Asma F Ghannam, et al.
Allergy & Rhinology (Providence, R.I.)|June 2, 2017
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitisCraig F LaForce, Warner Carr, Stephen A Tilles, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
Allergy and Asthma Proceedings|March 23, 2010
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitisCraig F LaForce, Warner Carr, Stephen A Tilles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 11, 2005
Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapyWilliam Berger, Mark B Abelson, Paulo J Gomes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2010
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by classMichael Benninger, Judith R Farrar, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2007
American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthmaJohn M Weiler, Sergio Bonini, Robert Coifman, et al.
The World Allergy Organization Journal|April 2, 2015
A World Allergy Organization international survey on physical activity as a treatment option for asthma and allergiesAndre Moreira, Matteo Bonini, Ruby Pawankar, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2011
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice ParametersBradley Chipps, Sheldon Spector, Judith Farrar, et al.
Pageof 3